Pier Luigi Antignani
Overview
Explore the profile of Pier Luigi Antignani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Antignani P, Poredos P, Gastaldi G, Spirkoska A, Mansilha A
Int Angiol
. 2025 Feb;
PMID: 39932499
No abstract available.
2.
Jensterle M, Blinc A, Mikhailidis D, Anagnostis P, Schernthaner G, Antignani P, et al.
Curr Vasc Pharmacol
. 2024 Dec;
PMID: 39633519
No abstract available.
3.
Blinc A, Paraskevas K, Stanek A, Jawien A, Antignani P, Mansilha A, et al.
Int Angiol
. 2024 Oct;
43(4):458-467.
PMID: 39463151
Adherence to the Mediterranean diet (MeD) has been associated with a reduced incidence of peripheral arterial disease (PAD)/lower extremity arterial disease (LEAD) in observational trials and in a randomized trial....
4.
Paraskevas K, Poredos P, Stanek A, Blinc A, Jawien A, Antignani P, et al.
Int Angiol
. 2024 Sep;
43(4):450-457.
PMID: 39302145
Introduction: Dyslipidemia is an established risk factor for cardiovascular diseases. We aimed to review its role in the pathogenesis of lower extremity arterial disease (LEAD), as well as the effect...
5.
Poredos P, Paraskevas K, Mikhailidis D, Stanek A, Jawien A, Antignani P, et al.
Int Angiol
. 2024 Jul;
43(3):374-377.
PMID: 39045665
This article briefly discusses the risk factors for the development of lower extremity artery disease, namely smoking, diabetes mellitus, hyperlipidemia/dyslipidemia and hypertension. Each of these risk factors will be discussed...
6.
Stanek A, Mikhailidis D, Paraskevas K, Jawien A, Antignani P, Mansilha A, et al.
Int Angiol
. 2024 Jul;
43(3):367-373.
PMID: 39041784
Diabetes mellitus (DM) is a major risk factor for lower extremity arterial disease (LEAD) and about 20% of symptomatic patients with LEAD have DM. In subjects with DM, LEAD is...
7.
Palena L, Isernia G, Parlani G, Veroux P, Ficarelli I, Frascheri A, et al.
Catheter Cardiovasc Interv
. 2024 Apr;
103(6):963-971.
PMID: 38566517
Background: Complex femoropopliteal artery disease represents a challenge. The Supera stent holds the promise of improving the results of endovascular therapy for complex femoropopliteal disease. Aims: We aimed at appraising...
8.
Anagnostis P, Mikhailidis D, Blinc A, Jensterle M, Jezovnik M, Schernthaner G, et al.
Curr Vasc Pharmacol
. 2024 Feb;
22(2):153-154.
PMID: 38321894
No abstract available.
9.
Antignani P, Jezovnik M, Blinc A, Mikhailidis D, Anagnostis P, Schernthaner G, et al.
Curr Vasc Pharmacol
. 2024 Jan;
22(2):88-94.
PMID: 38284694
Primary hyperparathyroidism (PHPT) is presented in various forms, including classic PHPT, characterised by increased parathyroid hormone (PTH) secretion, normohormonal PHPT, and normocalcaemic PHPT. Secondary hyperparathyroidism is characterised by increased PTH...
10.
Studen K, Gaberscek S, Zaletel K, Blinc A, Sabovic M, Schernthaner G, et al.
Curr Vasc Pharmacol
. 2023 Nov;
22(1):36-40.
PMID: 37957913
Hypothyroidism and hyperthyroidism, both overt and subclinical, are associated with increased risk of cardiovascular morbidity and mortality. The association between thyroid-stimulating hormone levels and cardiovascular risk has been demonstrated in...